Last reviewed · How we verify
NCT04872777
Mobile Health Delivered Lifestyle Intervention Program in Patients With NASH
NA trial testing Noom Healthy Weight in Non-alcoholic Steatohepatitis in 40 participants. Completed in 10 February 2022.
10 February 2022
Quick facts
| Lead sponsor | Milton S. Hershey Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 8 June 2021 |
| Primary completion | 10 February 2022 |
| Estimated completion | 10 February 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Noom Healthy Weight
Conditions studied
- Non-alcoholic Steatohepatitis — all drugs for Non-alcoholic Steatohepatitis →
Sponsor
Milton S. Hershey Medical Center
Who can join
18 and older, any sex, with Non-alcoholic Steatohepatitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
There is a clear unmet clinical need for effective lifestyle intervention in patients with nonalcoholic steatohepatitis (NASH). Patients have self-identified multiple barriers to effective lifestyle intervention can be removed with a mobile health (mHealth) platform. This study will be a proof of concept study to evaluate weight loss efficacy of Noom Healthy Weight (HW), a mHealth lifestyle intervention, in patients with NASH.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Mobile health lifestyle intervention program leads to clinically significant loss of body weight in patients with NASH.
Stine JG, Rivas G, Rivas G, Hummer B, et al · · 2023 · cited 24× · PMID 36930864 · DOI 10.1097/hc9.0000000000000052
Verify or expand the search:
- PubMed search for NCT04872777
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Noom Healthy Weight
Trials testing the same drug.
- NCT04871295 — Improving Quality of Life in Men and Women With Overweight or Obesity · NA · completed
Other recruiting trials for Non-alcoholic Steatohepatitis
Currently open trials in the same condition.
- NCT05945537 — A Study of INI-822 in Healthy Volunteers and Participants with Non-alcoholic Steatohepatitis (NASH) or Presumed NASH · Phase 1 · recruiting
- NCT05462353 — Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 Tablets in Adult Patients With NASH · Phase 2 · active not recruiting
- NCT05573204 — Comparative Study Between Obeticholic Acid Versus Vitamin E in Patients with Non-alcoholic Steatohepatitis · Phase 2 · active not recruiting
- NCT04822181 — Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH) · Phase 3 · active not recruiting
- NCT04666402 — Integrated Diagnostics for Early Diagnosis of Liver Disease · recruiting
Other Milton S. Hershey Medical Center trials
Trials by the same sponsor.
- NCT05180552 — The HEALiX: Comparing the Efficacy of the HEALiX Device With Wrist Restraints in a Critical Care Setting · NA · withdrawn
- NCT07461844 — Transdiagnostic Sleep and Circadian Treatment for Autistic Adults · NA · not yet recruiting
- NCT06253858 — Ultrasound (US) Guided External Ventricular Catheter Placement · NA · not yet recruiting
- NCT07225699 — IN PATIENTS WITH CORNEAL ABRASIONS TREATED WITH COLLAGEN CORNEAL SHIELDS IN THE EMERGENCY DEPARTMENT SETTING · NA · not yet recruiting
- NCT07461168 — Penn State Emergency Medicine CarES: Care-partner Evaluation and Sourcing in the Emergency Department · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04872777 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Milton S. Hershey Medical Center
- Last refreshed: 2 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04872777.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing